vimarsana.com

சர்வதேச சபை ஆஃப் உயிரி தொழில்நுட்பவியல் சங்கங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Has the threat of waiving COVID vaccine IP rights had its desired effect?

Has the threat of waiving COVID vaccine IP rights had its desired effect?
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

POET documents benefits of biofuel | The Mexico Ledger

Steve Sinning comes from a long line of farmers. His father was a farmer. His grandfather was a farmer. Even his great-grandfather was a farmer. “I’ve been farming since the mid-’70s,” Sinning said. “But it’s really been all my life. I grew up on a farm the same farm I’m on today. Dad grew up here, too. I’m a fourth-generation farmer, and my son will be the fifth.” For decades, Sinning’s family has played a vital role in putting food on America’s table. But today, they’re helping meet America’s energy needs, too.

Preserving biotech s IP rights

Date Time Preserving biotech’s IP rights AusBiotech has joined BIO, the UK BioIndustry Association, and more than 290 other global biotech company leaders as they unite in their concern of the ongoing risk to international IP protection that is before the World Trade Organization (WTO). As currently experienced across Australia, accessing COVID-19 vaccines and essential treatments is being hampered by manufacturing abilities and supply chains, rather than due to access to the IP that backs them. Despite voluntary global agreements and more collaboration and partnerships in biotech than ever before, a misguided understanding of equitable access remains and the proposal to waive IP protection that is before the WTO will not overcome the real barriers.

Quest for Research Freedom Fuels African Biotech Boom

Quest for Research Freedom Fuels African Biotech Boom Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab. Linda Nordling Jul 1, 2021 54GENE Returning to his native Ghana after a postdoc in the United Kingdom, Yaw Bediako thought he had his future pretty much mapped out. “I felt everything was leading me to the usual model of academic research full professor before I’m forty-five, with my own research group, a good grant portfolio, and students working for me,” the immunologist says. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.